Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical pharmacology and therapy

• Publication date

  2001-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1067/mcp.2001.116793PMID 11452244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of methadone during maintenance treatment: Adaptive changes during the induction phase

  2004cited by this paper
• The pharmacokinetics of methadone in healthy subjects and opiate users.

  2003cited by this paper
• Development and application of a chiral high performance liquid chromatography assay for pharmacokinetic studies of methadone.

  2000cited by this paper
• Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.

  2000cited by this paper
• Opiate-induced Analgesia Is Increased and Prolonged in Mice Lacking P-glycoprotein

  2000cited by this paper
• Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome.

  2000cited by this paper
• Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes.

  1999cited by this paper
• Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.

  1999cited by this paper
• d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.

  1999cited by this paper
• The genetic variant A of human alpha 1-acid glycoprotein limits the blood to brain transfer of drugs it binds.

  1998cited by this paper
• High interindividual variability of methadone enantiomer blood levels to dose ratios.

  1998cited by this paper
• HIGH INTERINDIVIDUAL VARIABILITY OF METHADONE ENANTIOMER BLOOD LEVELS TO DOSE RATIOS

  1998cited by this paper
• Enantioselective high-performance liquid chromatography determination of methadone enantiomers and its major metabolite in human biological fluids using a new derivatized cyclodextrin-bonded phase.

  1997cited by this paper
• Interaction of methadone with substrates of human hepatic cytochrome P450 3A4.

  1997cited by this paper
• d-Methadone Is Antinociceptive in the Rat Formalin Test 1

  1997cited by this paper
• Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.

  1997cited by this paper
• d-Methadone is antinociceptive in the rat formalin test.

  1997cited by this paper
• Stereoselective determination of methadone in serum by HPLC following solid-phase extraction on disk.

  1996cited by this paper
• Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.

  1996cited by this paper
• Cytochrome P4503A (CYP3A) metabolism: Prediction ofIn Vivo activity in humans

  1996cited by this paper
• Replacement of (R)-methadone by a double dose of (R, S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics

  1996cited by this paper
• Urinary 6 beta-hydroxycortisol in humans: analysis, biological variations, and reference ranges.

  1995cited by this paper
• Enantioselective high-performance liquid chromatographic method for the determination of methadone in serum using an AGP and a CN column as chiral and analytical column, respectively.

  1994cited by this paper
• Sensitive high-performance liquid chromatographic assay with ultraviolet detection of methadone enantiomers in plasma.

  1994cited by this paper
• Probable Metabolic Interaction Between Methadone and Fluvoxamine in Addict Patients

  1994cited by this paper
• Simultaneous determination of urinary free cortisol and 6 beta-hydroxycortisol by high-performance liquid chromatography to measure human CYP3A activity.

  1994cited by this paper
• Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review

  1994cited by this paper
• The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes.

  1994cited by this paper
• Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.

  1993cited by this paper
• Stereoselective pharmacokinetics of methadone in chronic pain patients.

  1993cited by this paper
• Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells.

  1993cited by this paper
• Methadone in the management of cancer pain: a review.

  1993cited by this paper
• Stereospecific gas chromatographic method for determination of methadone in serum.

  1992cited by this paper
• Methadone concentrations in plasma and their relationship to drug dosage.

  1991cited by this paper
• Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification.

  1990cited by this paper
• Binding of d‐methadone, 1‐methadone, and dl‐methadone to proteins in plasma of healthy volunteers: Role of the variants of α1‐acid glycoprotein

  1990cited by this paper
• The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.

  1989cited by this paper
• Drug binding to human alpha-1-acid glycoprotein in health and disease.

  1988cited by this paper
• Quantitation of methadone enantiomers in humans using stable isotope-labeled [2H3]-, [2H5]-, and [2H8]Methadone.

  1982cited by this paper
• Stereoselective disposition of methadone in man.

  1979cited by this paper
• Side effects of levomethadone and racemic methadone in a maintenance program

  1976cited by this paper
• A Review of the

  year unknowncited by this paper

• Population Pharmacokinetics of Intravenous Methadone Enantiomers in Adults: A Comprehensive Model

  2025cites this paper
• Stereoselective methadone disposition after administration of racemic methadone to anesthetized Shetland ponies assessed by capillary electrophoresis

  2021cites this paper
• Brain/blood ratios of methadone and ABCB1 polymorphisms in methadone-related deaths

  2021cites this paper
• The effect of a methadone reformulation on opioid agonist treatment outcomes: A population-based study in British Columbia, Canada, 2013-14.

  2021cites this paper
• Precision dosing of methadone during pregnancy: A pharmacokinetics virtual clinical trials study.

  2021cites this paper
• Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone

  2020cites this paper
• Pharmacogenomics of methadone: a narrative review of literature.

  2020cites this paper
• Role of cytochrome P450 2B6 polymorphisms in unexpected methadone death

  2019cites this paper
• The optimisation of methadone dosing whilst treating with rifampicin: a pharmacokinetic study

  2019cites this paper
• The optimization of methadone dosing whilst treating with rifampicin: A pharmacokinetic modeling study.

  2019cites this paper
• Utilizing Pediatric Physiologically Based Pharmacokinetic Models to Examine Factors That Contribute to Methadone Pharmacokinetic Variability in Neonatal Abstinence Syndrome Patients

  2019cites this paper
• Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics

  2018cites this paper
• First report on orally administered methadone to multi-drug resistance (MDR1) gene normal horses

  2018cites this paper
• The need for patient-tailored dosing of baclofen in future clinical trials☆.

  2018cites this paper
• Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities.

  2017cites this paper
• Determination of the unbound fraction of R- and S-methadone in human brain

  2016cites this paper
• Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir

  2015cites this paper
• Gender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapy

  2015cites this paper
• Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.

  2015cites this paper
• Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.

  2014cites this paper
• Fatal methadone toxicity: potential role of CYP3A4 genetic polymorphism.

  2014cites this paper
• State in Patients on Methadone Therapy Voriconazole and Methadone at Steady Pharmacokinetic Interaction between

  2014cites this paper
• Ethnic and genetic factors in methadone pharmacokinetics: a population pharmacokinetic study.

  2014cites this paper
• Methadone population pharmacokinetics: toward understanding the dose-response relationship in the treatment of opiate addiction

  2013cites this paper
• Methadone Pharmacodynamics and Pharmacokinetics

  2013cites this paper
• Moving toward Personalized Medicine in the Methadone Maintenance Treatment Program: A Pilot Study on the Evaluation of Treatment Responses in Taiwan

  2013cites this paper
• Pharmacokinetic-Pharmacodynamic Modeling of Mood and Withdrawal Symptoms in Relation to Plasma Concentrations of Methadone in Patients Undergoing Methadone Maintenance Treatment

  2012cites this paper
• Evaluating the relationship of methadone concentrations and EDDP formation in chronic pain patients.

  2012cites this paper
• Recherche de facteurs génétiques intervenant dans la variabilité de la réponse aux opioïdes dans le traitement de la douleur et les traitements de substitution

  2012cites this paper
• Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.

  2012cites this paper
• Cation-selective exhaustive injection and sweeping micellar electrokinetic chromatography for the analysis of methadone and its metabolites in serum of heroin addicts.

  2011cites this paper
• The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence

  2011cites this paper
• Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships of Methadone in a Sample of Iranian (Mazandarani) Opiate Users Undergoing Methadone Maintenance Treatment

  2011cites this paper
• Cause of Death Conundrum With Methadone Use: A Case Report

  2011cites this paper
• PRECLINICAL STUDY: Mechanisms of respiratory insufficiency induced by methadone overdose in rats

  2010cites this paper
• Role of gastrointestinal multidrug resistance (MDR1) gene and P-glycoprotein (P-gp) in the oral absorption of methadone in horses

  2010cites this paper
• Pediatric Palliative Care

  2009cites this paper
• Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment.

  2009cites this paper
• Pharmacokinetics of the injectable formulation of methadone hydrochloride administered orally in horses.

  2009cites this paper
• Feasability and safety of transfer from racemic methadone to (R)-methadone in primary care: Clinical results from an open study

  2009cites this paper
• An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes.

  2008cites this paper
• Interindividual Variability of Methadone Response

  2008cites this paper
• The Effects of Maternally Administered Methadone, Buprenorphine and Naltrexone on Offspring: Review of Human and Animal Data

  2008influential citation
• Role of CYP2B6 in Stereoselective Human Methadone Metabolism

  2008influential citation
• Case report: quantification of methadone-induced respiratory depression using toxicokinetic/toxicodynamic relationships

  2007influential citation
• Enantiomeric Metabolic Interactions and Stereoselective Human Methadone Metabolism

  2007influential citation
• The analgesic mechanisms of buprenorphine

  2006cites this paper
• Population-Based Analysis of Methadone Distribution and Metabolism Using an Age-Dependent Physiologically Based Pharmacokinetic Model

  2006cites this paper
• Multi-drug resistance gene (MDR1) and opioid analgesia in horses

  2006cites this paper
• Suchttherapeutika zur Sucht

  2006cites this paper
• Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers in Hospice Patients With Cancer Pain

  2006cites this paper
• Pharmacokinetic Interaction between Voriconazole and Methadone at Steady State in Patients on Methadone Therapy

  2006influential citation
• Pharmacokinetic Interaction between Voriconazole and Methadone at Steady State in Patients on Methadone Therapy (cid:1)

  2006influential citation
• THE ANALGESIC MECHANISMS OF BUPRENORPHINE Poli

  2005cites this paper
• Peginterferon Alfa‐2a Does Not Alter the Pharmacokinetics of Methadone in Patients with Chronic Hepatitis C Undergoing Methadone Maintenance Therapy

  2005cites this paper
• Pharmacokinetics of Methadone

  2005cites this paper
• Changes to methadone clearance during pregnancy

  2005cites this paper
• Determination of free and protein-bound methadone and its major metabolite EDDP: enantiomeric separation and quantitation by LC/MS/MS.

  2005cites this paper
• Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects.

  2005cites this paper
• Determination of total and free concentrations of the enantiomers of methadone and its metabolite (2-ethylidene-1,5-dimethyl-3,3-diphenyl-pyrrolidine) in human plasma by enantioselective liquid chromatography with mass spectrometric detection.

  2005cites this paper
• Pharmacokinetic-pharmacodynamic modeling of opioids.

  2005cites this paper
• Proceedings of the Symposium "Updates of the Clinical Pharmacology of Opioids with Special Attention to Long-Acting Drugs"

  2005cites this paper
• The Acute Disposition of (R)- and (S)-Methadone in Brain and Lung of Sheep

  2005cites this paper
• Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood–brain barrier of Abcb1a gene knockout mice

  2004influential citation
• Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.

  2004cites this paper
• Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone

  2004cites this paper
• Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure.

  2004cites this paper
• The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone.

  2004cites this paper
• Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro.

  2003cites this paper
• Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses.

  2003cites this paper
• INVOLVEMENT OF CYP 3 A 4 , CYP 2 C 8 , AND CYP 2 D 6 IN THE METABOLISM OF ( R )-AND ( S )-METHADONE IN VITRO

  2003cites this paper
• Stir bar sorptive extraction-thermal desorption-capillary GC-MS for profiling and target component analysis of pharmaceutical drugs in urine.

  2003cites this paper
• Demographics, Assessment and Management of Pain in the Elderly

  2003cites this paper
• Interindividual Variability of the Clinical Pharmacokinetics of Methadone

  2002influential citation
• Great Expectations in Stereochemistry: Focus on Antidepressants

  2002cites this paper
• Stir bar sorptive extraction–thermal desorption–capillary GC–MS applied to biological fluids

  2002cites this paper